Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$650M |
| 2 |
Apple
AAPL
|
+$468M |
| 3 |
Marvell Technology
MRVL
|
+$458M |
| 4 |
Chevron
CVX
|
+$410M |
| 5 |
WIX.com
WIX
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$836M |
| 2 |
Bloom Energy
BE
|
+$727M |
| 3 |
Accenture
ACN
|
+$563M |
| 4 |
Broadcom
AVGO
|
+$549M |
| 5 |
Lam Research
LRCX
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.76% |
| 2 | Financials | 11.48% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.37% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBRX
3201
LB Pharmaceuticals
LBRX
$1.15B
| $1.22M | ﹤0.01% |
+77,450
| New | +$1.23M |
|
3202
Angi Inc
ANGI
$229M
| $1.22M | ﹤0.01% |
75,139
-16,460
| -18% | -$282K |
|
3203
IDEAYA Biosciences
IDYA
$3.42B
| $1.22M | ﹤0.01% |
44,880
+4,430
| +11% | +$107K |
|
3204
Invesco Semiconductors ETF
PSI
$2.29B
| $1.22M | ﹤0.01% |
17,360
-134,474
| -89% | -$8.52M |
|
3205
Tyra Biosciences
TYRA
$1.9B
| $1.22M | ﹤0.01% |
87,107
+6,505
| +8% | +$74.2K |
|
3206
JPMorgan Income ETF
JPIE
$10.1B
| $1.22M | ﹤0.01% |
26,197
+5,486
| +26% | +$254K |
|
3207
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.72B
| $1.21M | ﹤0.01% |
16,189
+4,808
| +42% | +$345K |
|
3208
Amplify Lithium & Battery Technology ETF
BATT
$115M
| $1.21M | ﹤0.01% |
93,123
-3,971
| -4% | -$42.8K |
|
3209
Invesco S&P 500 Value with Momentum ETF
SPVM
$129M
| $1.21M | ﹤0.01% |
18,374
+14,920
| +432% | +$939K |
|
3210
Canadian Natural Resources
CNQ
$99.4B
| $1.21M | ﹤0.01% |
37,776
-1,080
| -3% | -$33.8K |
|
3211
The RMR Group
RMR
$325M
| $1.21M | ﹤0.01% |
76,615
-42,243
| -36% | -$706K |
|
3212
Shutterstock
SSTK
$198M
| $1.2M | ﹤0.01% |
57,591
-112,885
| -66% | -$2.3M |
|
3213
Gogo Inc
GOGO
$565M
| $1.2M | ﹤0.01% |
139,322
+19,666
| +16% | +$249K |
|
3214
ALX Oncology
ALXO
$261M
| $1.19M | ﹤0.01% |
+652,897
| New | +$565K |
|
3215
TC Energy
TRP
$70.2B
| $1.19M | ﹤0.01% |
19,803
+406
| +2% | +$20.4K |
|
3216
Invesco S&P MidCap 400 Pure Value ETF
RFV
$335M
| $1.19M | ﹤0.01% |
9,288
+1,589
| +21% | +$202K |
|
|
EB
3217
DELISTED
Eventbrite
EB
| $1.19M | ﹤0.01% |
472,531
+156,249
| +49% | +$408K |
|
3218
CALL
GitLab
GTLB
$5.83B
| $1.19M | ﹤0.01% |
+26,400
| New | +$1.21M |
|
3219
Amplitude
AMPL
$1.18B
| $1.19M | ﹤0.01% |
+110,972
| New | +$1.32M |
|
3220
Home Bancorp
HBCP
$561M
| $1.19M | ﹤0.01% |
21,898
+4,813
| +28% | +$264K |
|
3221
Shenandoah Telecom
SHEN
$664M
| $1.19M | ﹤0.01% |
88,612
-8,299
| -9% | -$114K |
|
3222
Viant Technology
DSP
$236M
| $1.18M | ﹤0.01% |
137,178
+40,581
| +42% | +$463K |
|
|
NEMD
3223
Neuberger Emerging Markets Debt Hard Currency ETF
NEMD
$137M
| $1.18M | ﹤0.01% |
+23,220
| New | +$1.18M |
|
3224
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.94B
| $1.18M | ﹤0.01% |
+42,777
| New | +$1.16M |
|
3225
iShares JPMorgan EM Corporate Bond ETF
CEMB
$398M
| $1.18M | ﹤0.01% |
25,550
+5,932
| +30% | +$271K |
|
Similar funds
Ameriprise's Q3 2025 Portfolio in Review
As of Q3 2025, Ameriprise held 4,210 positions worth $435B, up 7.3% from $406B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ameriprise's Q3 2025 filing shows 266 new, 1,586 increased, 2,101 reduced and 160 closed positions. Its largest new stake was Aptiv: 3,450,314 shares worth $298M. The largest sale was Microsoft, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q3 2025 buy was Aptiv: 3,450,314 shares worth $298M.
- Ameriprise added most to Applied Materials in Q3 2025, an estimated $650M increase.
- Ameriprise's biggest Q3 2025 reduction was Microsoft, cutting an estimated $836M.
- Ameriprise fully exited Hess in Q3 2025, selling an estimated $77.2M.
- Ameriprise's ten largest holdings make up 22% of its $435B portfolio in Q3 2025.
- Ameriprise opened 266 new positions and closed 160 in Q3 2025.
- Ameriprise's portfolio value rose 7.3% quarter-over-quarter to $435B.
Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.